ArticleCancer drug resistance (Alhambra, Calif.)2025

Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancer.

Chao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.